XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Private placement
Common Stock
Additional Paid-in Capital
Private placement
Additional Paid-in Capital
Accumulated Deficit
Private placement
Total
Balance at beginning of period at Dec. 31, 2016   $ 17   $ 47,674 $ (27,059)   $ 20,632
Balance at end of period (shares) at Mar. 31, 2017   10,596,838          
Balance at beginning of period (shares) at Dec. 31, 2016   9,270,255          
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock $ 1   $ 8,978     $ 8,979  
Issuance of common stock (in shares) 1,324,256            
Issuance of detachable stock warrants in connection with private placement offering     3,562     3,562  
Issuance costs     (1,219)     (1,219)  
Exercise of stock options       3     3
Exercise of stock options (in shares)   2,327          
Share-based compensation - employee       829     829
Share-based compensation - non-employee       7     7
Net loss         (7,496)   (7,496)
Balance at end of period at Mar. 31, 2017   $ 18   59,834 (34,555)   25,297
Balance at beginning of period at Dec. 31, 2016   $ 17   47,674 (27,059)   $ 20,632
Balance at end of period (shares) at Sep. 30, 2017   10,633,042          
Balance at beginning of period (shares) at Dec. 31, 2016   9,270,255          
Increase (Decrease) in Stockholders' Equity              
Exercise of warrants (in shares)             0
Net loss             $ (26,669)
Balance at end of period at Sep. 30, 2017   $ 18   63,659 (53,728)   9,949
Balance at beginning of period at Dec. 31, 2016   $ 17   47,674 (27,059)   20,632
Balance at end of period (shares) at Dec. 31, 2017   10,633,042          
Balance at beginning of period (shares) at Dec. 31, 2016   9,270,255          
Balance at end of period at Dec. 31, 2017   $ 18   64,397 (60,474)   3,941
Balance at beginning of period at Mar. 31, 2017   $ 18   59,834 (34,555)   25,297
Balance at end of period (shares) at Jun. 30, 2017   10,607,361          
Balance at beginning of period (shares) at Mar. 31, 2017   10,596,838          
Increase (Decrease) in Stockholders' Equity              
Issuance costs     (38)     (38)  
Exercise of stock options       10     10
Exercise of stock options (in shares)   10,523          
Share-based compensation - employee       2,955     2,955
Share-based compensation - non-employee       8     8
Net loss         (10,502)   (10,502)
Balance at end of period at Jun. 30, 2017   $ 18   62,769 (45,057)   17,730
Balance at end of period (shares) at Sep. 30, 2017   10,633,042          
Balance at beginning of period (shares) at Jun. 30, 2017   10,607,361          
Increase (Decrease) in Stockholders' Equity              
Issuance of detachable stock warrants in connection with private placement offering       156     156
Exercise of warrants (in shares)   15,000          
Issuance costs     $ (30)     $ (30)  
Exercise of stock options       28     28
Exercise of stock options (in shares)   10,681          
Share-based compensation - employee       726     726
Share-based compensation - non-employee       10     10
Net loss         (8,671)   (8,671)
Balance at end of period at Sep. 30, 2017   $ 18   63,659 (53,728)   9,949
Balance at beginning of period at Dec. 31, 2017   $ 18   64,397 (60,474)   3,941
Balance at end of period (shares) at Mar. 31, 2018   14,232,313          
Balance at beginning of period (shares) at Dec. 31, 2017   10,633,042          
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock   $ 4   25,146     $ 25,150
Issuance of common stock (in shares)   3,592,858         3,592,858
Issuance costs       (2,093)     $ (2,093)
Exercise of stock options       23     23
Exercise of stock options (in shares)   6,413          
Share-based compensation - employee       1,019     1,019
Share-based compensation - non-employee       1     1
Net loss         (7,224)   (7,224)
Balance at end of period at Mar. 31, 2018   $ 22   88,493 (67,698)   20,817
Balance at beginning of period at Dec. 31, 2017   $ 18   64,397 (60,474)   $ 3,941
Balance at end of period (shares) at Sep. 30, 2018   14,265,411          
Balance at beginning of period (shares) at Dec. 31, 2017   10,633,042          
Increase (Decrease) in Stockholders' Equity              
Exercise of warrants (in shares)             0
Net loss             $ (19,981)
Balance at end of period at Sep. 30, 2018   $ 22   91,286 (80,455)   10,853
Balance at beginning of period at Mar. 31, 2018   $ 22   88,493 (67,698)   20,817
Balance at end of period (shares) at Jun. 30, 2018   14,232,313          
Balance at beginning of period (shares) at Mar. 31, 2018   14,232,313          
Increase (Decrease) in Stockholders' Equity              
Share-based compensation - employee       908     908
Share-based compensation - non-employee       1     1
Net loss         (6,678)   (6,678)
Balance at end of period at Jun. 30, 2018   $ 22   89,402 (74,376)   15,048
Balance at end of period (shares) at Sep. 30, 2018   14,265,411          
Balance at beginning of period (shares) at Jun. 30, 2018   14,232,313          
Increase (Decrease) in Stockholders' Equity              
Issuance of detachable stock warrants in connection with private placement offering       196     196
Exercise of stock options       61     61
Exercise of stock options (in shares)   33,098          
Share-based compensation - employee       1,626     1,626
Share-based compensation - non-employee       1     1
Net loss         (6,079)   (6,079)
Balance at end of period at Sep. 30, 2018   $ 22   $ 91,286 $ (80,455)   $ 10,853